News & ArticlesLatest news and informative articles
It’s been a busy few months for S-cubed. Find out where we’ve been and where we’re going to next.
Statistics and the impact of machine learning get Elizabeth Merrall thinking and considering the future.
Our latest Industry Insights focuses on Brexit and news from the regulators around the globe.
As we head to the CDISC Interchange this week, make sure you see our presentations and meet our team at Stand 11.
S-cubed is pleased to announce that S-cubed and A3 Informatics have merged to bring the A3 Suite of tools inside the S-cubed brand.
Regulatory Affairs and Quality Assurance – S-cubed Ltd are 10 years old. Find out about how our team came together and continue to grow.
The latest papers and presentations from PhUSE US Connect in Baltimore and our future events, including CDISC.
Our first Industry Insights of 2019 focuses on the latest regulatory developments and Brexit.
A fascinating talk by the Keynote Speaker, Dr Ahadpour from the FDA on the opioid addiction crisis in the USA.
Jakob Sandersen reports on the exciting developments at Pharmaceutical Services ApS over the last 15 months.
Learn all about our presentations at PhUSE US Connect in Baltimore and at the CDISC Interchange in Amsterdam
The final report from Larissa Gould on the SME Day at EMA focuses on the Committee for Advanced Therapies, new Medical Devices Regulation and a Brexit update.
Our Qlik Team are proud to announce that they have been awarded Pharmaceutical and Biotech Specialization status.
Part Two of the report from the SME Day at the EMA focuses on Marketing Authorisations and more.
Larissa Gould reports from the EMA in Canary Wharf on the latest developments.
Our latest industry update covers news about Brexit, from FDA, EMA and more.
Our Qlik Team are on Tour in Stockholm. Be part of the Data Revolution and join them there!
Our staff and events teams are working hard, as we head towards the end of the year.
We look forward to seeing you at PhUSE or our CDISC Public training in November.
Stephen Thompson, our regulatory affairs Director, writes about the latest Brexit news.
Our latest update from the industry reflects the ongoing uncertainty around BREXIT.
Bohua Li introduces an S-cubed extension for adding user comments in a Qlik Sense application, along with a guide for users to implement the extension themselves.
This article provides an overview of PRIME, Breakthrough Therapy and Fast Track regulatory procedures intended to optimise the development of medicines that target an unmet medical need.
Regulatory Affairs Expert Tony Mitchell co-authors a case study for a new IBS Drug This is case study for a joint project S-cubed worked on for a new drug for IBS – PharmaVentures was the lead company and they were providing market valuation expertise, Apex Healthcare...
Sign up to receive our Industry Insights every quarter
Sign up for our newsletter
Download our latest publication
- UK – Fast Track to Ground Breaking Medicines
- US Real Word Data
- Policies Consultations and Guidelines